Abstract
Frontline HCVAD with Nelarabine and Peg-Asparaginase in T-Acute Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LBL): Updated Results of a Phase II Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have